SCHEMBL7700375

SCHEMBL7700375

CCCCOC(=O)N=C(NC(=O)OCCCC)c1cc[nH]n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 10/20 0.38
NPC1 O15118 8/20 0.38
SMN1; SMN2 Q16637 8/20 0.38
CYP1A2 P05177 4/20 0.38
CYP2C19 P33261 4/20 0.38
ALDH1A1 P00352 3/20 0.38
NFKB1 P19838 2/20 0.38
NFKB2 Q00653 2/20 0.38
RELA Q04206 2/20 0.38
STAT1 P42224 1/20 0.38
HPGD P15428 6/20 0.37
L3MBTL1 Q9Y468 4/20 0.37
KDM4E B2RXH2 2/20 0.37
MAPT P10636 2/20 0.37
CASP1 P29466 1/20 0.37
MAPK1 P28482 1/20 0.37
MCL1 Q07820 1/20 0.37
LMNA P02545 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
CYP2C9 P11712 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7692176 0.80 TSHR (0.38) RAB9ANPC1SMN1; SMN2CYP1A2CYP2C19
SCHEMBL4726369 0.76 CA12 (0.41) RAB9ANPC1SMN1; SMN2LMNA
SCHEMBL7989497 0.75 RAB9A (0.41) RAB9ANPC1SMN1; SMN2CYP1A2CYP2C19
SCHEMBL7989499 0.75 RAB9A (0.41) RAB9ANPC1SMN1; SMN2CYP1A2CYP2C19
SCHEMBL20570815 0.74 TSHR (0.53) SMN1; SMN2CYP1A2CYP2C19ALDH1A1HPGD
SCHEMBL27970370 0.73 TSHR (0.51) SMN1; SMN2CYP1A2CYP2C19ALDH1A1HPGD
SCHEMBL900423 0.72 RAB9A (0.36) RAB9ANPC1SMN1; SMN2ALDH1A1NFKB1
SCHEMBL29291579 0.70 TSHR (0.54) RAB9ANPC1SMN1; SMN2CYP1A2CYP2C19
SCHEMBL29126825 0.69 ALDH1A1 (0.55) RAB9ANPC1ALDH1A1L3MBTL1KDM4E
SCHEMBL6343556 0.68 EPHX1 (0.43) RAB9ANPC1SMN1; SMN2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6344484-B1 TREATMENT OF TUMOR GROWTH, METASTASIS, OSTEOPOROSIS, RESTENOSIS, INFLAMMATION, MACULAR DEGENERATION, DIABETIC RETINOPATHY, AND RHEUMATOID ARTHRITIS 3-DIMENSIONAL PHARMACEUTICALS, INC. 2002-02-05 US disclosed